Surfactant protein A suppresses lung cancer progression by regulating the polarization of tumor-associated macrophages.

Published

Journal Article

Surfactant protein A (SP-A) is a large multimeric protein found in the lungs. In addition to its immunoregulatory function in infectious respiratory diseases, SP-A is also used as a marker of lung adenocarcinoma. Despite the finding that SP-A expression levels in cancer cells has a relationship with patient prognosis, the function of SP-A in lung cancer progression is unknown. We investigated the role of SP-A in lung cancer progression by introducing the SP-A gene into human lung adenocarcinoma cell lines. SP-A gene transduction suppressed the progression of tumor in subcutaneous xenograft or lung metastasis mouse models. Immunohistochemical analysis showed that the number of M1 antitumor tumor-associated macrophages (TAMs) was increased and the number of M2 tumor-promoting TAMs was not changed in the tumor tissue produced by SP-A-expressing cells. In addition, natural killer (NK) cells were also increased and activated in the SP-A-expressing tumor. Moreover, SP-A did not inhibit tumor progression in mice depleted of NK cells. Taking into account that SP-A did not directly activate NK cells, these results suggest that SP-A inhibited lung cancer progression by recruiting and activating NK cells via controlling the polarization of TAMs.

Full Text

Cited Authors

  • Mitsuhashi, A; Goto, H; Kuramoto, T; Tabata, S; Yukishige, S; Abe, S; Hanibuchi, M; Kakiuchi, S; Saijo, A; Aono, Y; Uehara, H; Yano, S; Ledford, JG; Sone, S; Nishioka, Y

Published Date

  • May 2013

Published In

Volume / Issue

  • 182 / 5

Start / End Page

  • 1843 - 1853

PubMed ID

  • 23499372

Pubmed Central ID

  • 23499372

Electronic International Standard Serial Number (EISSN)

  • 1525-2191

International Standard Serial Number (ISSN)

  • 0002-9440

Digital Object Identifier (DOI)

  • 10.1016/j.ajpath.2013.01.030

Language

  • eng